# OnCo record mediastinal-grey-zone-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/mediastinal-grey-zone-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "mediastinal-grey-zone-lymphoma" ;
  schema:name "Mediastinal grey zone lymphoma"@en ;
  schema:alternateName "Mediastinal gray zone lymphoma"@en, "MGZL"@en, "Grey zone lymphoma"@en, "Gray zone lymphoma"@en, "B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classic Hodgkin lymphoma"@en, "B-cell lymphoma unclassifiable"@en, "Intermediate DLBCL/CHL"@en ;
  schema:description "A lymphoma of the chest that sits between two diseases: it has some of the features of primary mediastinal B-cell lymphoma and some of classic Hodgkin lymphoma, and a pathologist cannot put it cleanly in either. It is recognised as an entity of its own, and the 2022 classifications restricted the name to lymphomas that involve the mediastinum."@en ;
  schema:url <https://onco.cc/cancers/mediastinal-grey-zone-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Primary_mediastinal_B-cell_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1038/bjc.2015.94>, <https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/ebv-positive-dlbcl/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/fdg-pet/> ;
  onco:targets <https://onco.cc/targets/cd30/>, <https://onco.cc/targets/cd20/> ;
  onco:terms <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-indolent-versus-aggressive/>, <https://onco.cc/terms/lugano-classification/>, <https://onco.cc/terms/deauville-score/>, <https://onco.cc/terms/lymphoma-tx-radiotherapy/> ;
  onco:standardOfCare <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/targets/cd30/>, <https://onco.cc/targets/cd20/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/terms/lymphoma-tx-regimen-alphabet/>, <https://onco.cc/terms/lymphoma-tx-radiotherapy/>, <https://onco.cc/terms/r-chop/> .